Richard DiVenuto former partner at Concept Capital Markets - which has offices in Boston, Massachusetts as well as New York, Florida, and California - and an authority in various aspects of biotech investments. In the past, Richard DiVenuto has worked with companies developing focused in cell therapy, which can help regulate autoimmune function to reduce the body’s pathological response to stimuli while still maintaining its disease-fighting abilities.
Mesenchymal stem cells are one of the fastest-growing types of treatments for autoimmune and degenerative diseases. Here are answers to some of the most common questions surrounding them:
Q: What are mesenchymal stem cells?
A: Adult stem cells that are present in various types of tissue, including bone marrow and fatty tissue.
Q: What are MSCs used for?
A: Broadly, they can supplement a person’s stem cell count through transplantation. This can help to regulate a number of functions, such as immune response.
Q: Why are they better than other treatments?
A: One of the key reasons MSCs are so effective is their immunoprivileged nature. They avoid a negative response from the immune system even though they are transplanted, so there is no risk of rejection when used as a treatment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.